I recently read a bestselling book called Thing Again: The Power of Knowing What You Don’t Know by Adam Grant. I have to admit that when...

After decades of working with clients in big pharma, we have spent countless hours on strategic tactical planning. In each instance,...

We are life-long learners at S+S{i}. We are passionate about emerging science and finding the best ways to communicate key clinical...

The 16th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) was held earlier this month. For the...

It’s been a few months since our last blog post, but needless to say, so much has changed. S+S{i} started off the year with a steady...

We have worked on countless medical education initiatives over the years that were successful and achieved the desired impact because of...

It has been a hectic fourth quarter and an overall positive time for Scientific + Strategic insights. It is a great time to reflect on...

When we posted best practices for live advisory board meetings, we received a few comments suggesting that live meetings are becoming...

The theme of this year’s American Academy of Ophthalmology (AAO) annual meeting was “Inspire” and we certainly left San Francisco feeling...

Most of us have experienced insomnia - that terrible feeling when all you want to do is sleep but you lie awake. The occasional bout of...

It is an incredible experience working with patient advocates. They are brave, inspiring, and committed to helping other people. We often...

It’s that time of year again. We are being alerted that influenza vaccinations are available and that flu season is right around the...

We have worked on many launches at S+S{i} and the opportunity to develop scientific platforms is one of the key reasons we find them so...

Advisory boards are an essential part of the work we do at S+S{i}. We have worked on advisory boards with medical affairs clients seeking...

There has been mounting buzz about biosimilars coming to market. The Food and Drug Administration (FDA) recently approved Hadlima

Many PowerPoint characteristics actually hinder the quality of thought for the presenter as well as the audience.